Non-Muscle Invasive Bladder Cancer: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 144: | Line 144: | ||
**** High risk of bias present in 12 of 13 publications. Quality of evidence for recurrence-free interval was very low and low for early recurrences. | **** High risk of bias present in 12 of 13 publications. Quality of evidence for recurrence-free interval was very low and low for early recurrences. | ||
**** Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. [https://pubmed.ncbi.nlm.nih.gov/29801011/ Perlis et. al.] Eur Urol. 2013 Sep;64(3):421-30. | **** Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. [https://pubmed.ncbi.nlm.nih.gov/29801011/ Perlis et. al.] Eur Urol. 2013 Sep;64(3):421-30. | ||
*** '''<span style="color:# | *** '''<span style="color:#ff00ff">SWOG 0337 (JAMA 2018)''' | ||
**** Population: ≈400 patients with suspected low-grade NIMBC undergoing TURBT | **** Population: ≈400 patients with suspected low-grade NIMBC undergoing TURBT | ||
**** Randomized to immediate post-TURBT intravesical instillation of gemcitabine vs saline | **** Randomized to immediate post-TURBT intravesical instillation of gemcitabine vs saline | ||